Anixa Biosciences

Yahoo Finance • 9 days ago

S&P Futures Steady After Rate-Cut Rally, Trump-Xi Call in Focus

September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.02% this morning, taking a breather after yesterday’s gains, with investors turning their attention to an expected phone call betwe... Full story

Yahoo Finance • 18 days ago

Anixa Biosciences files $200M mixed securities shelf

* Anixa Biosciences (NASDAQ:ANIX [https://seekingalpha.com/symbol/ANIX]) filed $200M mixed securities shelf. * Filing [https://seekingalpha.com/filing/10406401] MORE ON ANIXA BIOSCIENCES * Seeking Alpha’s Quant Rating on Anixa Bios... Full story

Yahoo Finance • 2 months ago

Anixa Biosciences secures new patent for solid tumor CAR-T technology

SAN JOSE, Calif. - Anixa Biosciences, Inc. (NASDAQ:ANIX), a clinical-stage biotechnology company with a market capitalization of $94.7 million, announced Tuesday that the United States Patent and Trademark Office has issued a new patent fo... Full story

Yahoo Finance • 3 months ago

Anixa Biosciences to receive new US patent for ovarian cancer vaccine

SAN JOSE - Anixa Biosciences, Inc. (NASDAQ:ANIX), a $101 million market cap biotechnology company whose stock has surged nearly 40% over the past six months, announced Wednesday that the United States Patent and Trademark Office will issue... Full story

Yahoo Finance • 3 months ago

H.C. Wainwright reiterates buy rating on Anixa Biosciences stock

Investing.com - H.C. Wainwright maintained its buy rating and $7.00 price target on Anixa Biosciences (NASDAQ:ANIX) following the company’s advancement in its ovarian cancer treatment trial. The clinical-stage biotech company operates in t... Full story

Yahoo Finance • 3 months ago

Anixa Biosciences doses first patient in fourth cohort of CAR-T trial

SAN JOSE - Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company with a market capitalization of approximately $109 million, has dosed the first patient in the fourth cohort of its Phase 1 clinical trial evaluating a chimeric ant... Full story

Yahoo Finance • 4 months ago

ANIXA BIOSCIENCES Earnings Preview: Recent $ANIX Insider Trading, Hedge Fund Activity, and More

ANIXA BIOSCIENCES ($ANIX) is expected to release its quarterly earnings data on Monday, June 2nd after market close, per Finnhub. Analysts are expecting revenue of $0 and earnings of -$0.10 per share. You can see Quiver Quantitative's $AN... Full story